Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 15, 2022Blood

Tafasitamab and Lenalidomide in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL): Real World Outcomes in a Multicenter Retrospective Study

View Full Paper
Ask AI
Bookmark
Share

Authors

DQDavid QuallsDana-Farber Cancer InstituteMBMichael J. BuegeIllinois CollegePDPhuong DaoMemorial Sloan Kettering Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Qualls et al. (2022) studied this question.

synapsesocial.com/papers/6a0872cbef79633196e8b8d9https://doi.org/10.1182/blood-2022-167620
View Full Paper
Ask AI
Bookmark
Share